CAS 151213-15-9

Acido 1-ciclopropil-6,8-difluoro-1,4-diidro-7-[(4aS,7aS)-ottaidro-6H-pirrolo[3,4-b]piridin-6-il]-4-osso-3-chinolinecarbossilico

Descrizione:

Acido 1-ciclopropil-6,8-difluoro-1,4-diidro-7-[(4aS,7aS)-ottaidro-6H-pirrolo[3,4-b]piridin-6-il]-4-osso-3-chinolinecarbossilico, con numero CAS 151213-15-9, è un composto organico sintetico caratterizzato dalla sua complessa struttura biciclica, che include un nucleo di chinolina e un moiety di pirrolopiridina. Questo composto presenta più gruppi funzionali, tra cui un acido carbossilico e sostituenti di fluoro, che possono influenzare la sua reattività chimica e attività biologica. La presenza del gruppo ciclopropilico può contribuire alle sue uniche proprietà steriche ed elettroniche. La sua complessità strutturale suggerisce potenziali applicazioni in chimica medicinale, in particolare nello sviluppo di farmaci mirati a specifiche vie biologiche. La difluorazione può migliorare la lipofilia e la stabilità metabolica, mentre l'architettura molecolare complessiva potrebbe essere progettata per interagire con recettori o enzimi specifici. Come per molti composti di questa natura, comprendere la sua solubilità, stabilità e interazione con sistemi biologici sarebbe cruciale per valutare i suoi potenziali usi terapeutici.

Formula: C₂₀H₂₁F₂N₃O₃

InChI: InChI=1/C20H21F2N3O3/c21-14-6-12-17(25(11-3-4-11)8-13(19(12)26)20(27)28)16(22)18(14)24-7-10-2-1-5-23-15(10)9-24/h6,8,10-11,15,23H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1

InChI key: InChIKey=WEXQOLCYKFJAJZ-ZUZCIYMTSA-N

SMILES: FC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N3C[C@]4([C@@](C3)(NCCC4)[H])[H])C5CC5

Sinonimi:

• 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
• 3-quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
• 6H-Pyrrolo[3,4-b]pyridine, 3-quinolinecarboxylic acid deriv.
• 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
• Moxifloxacin Imp. A RS IP
• Moxifloxacin hydrochloride impurity A
• Moxifloxacin Related CoMpound A
• Moxifloxacin impurity 1/Moxifloxacin EP Impurity A/Moxifloxacin Difluoro Analog/8-Desmethoxy-8-Fluoro Moxifloxacin/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• Moxifloxacin Related Matter 1
• Moxifloxacin impurity A
• 1-cyclopropyl-6-fluoro-7-amino-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-7-amino-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 7-amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxoquinoline-3-carboxylic acid
• 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- USP/EP/BP
• Moxifloxacin EP Impurity A : Moxifloxacin Impurity A
• 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
• Moxifloxacin EP IMpurity A
• Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
• 8-Desmethoxy-8-fluoro Moxifloxacin
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1
• Moxifloxacin Hydrochloride IMpurity-A(EP)(USPRC A)
• Moxifloxacin IMp. A (EP,BP)
• 8-Ddesmethoxy-8-fluoroMoxifloxacin
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• Moxifloxacin EP Impurity A HCl USP/EP/BP
• Moxifloxacin EP Impurity A/ Moxifloxacin Related Compound A (Moxifloxacin Difluoro Analog)
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-d
• Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
• Moxifloxacin related substance A
• USP Moxifloxacin Related Compound A
• Moxifloxacin impurity 2/Moxifloxacin EP Impurity A HCl/Moxifloxacin Difluoro Analog HCl/8-Desmethoxy-8-fluoro Moxifloxacin HCl/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Hydrochloride
• Moxifloxacin Related Matter A
• Mosisasin ImpurityA

Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)

CAS: 151213-15-9

Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticides

Formula: C₂₀H₂₁F₂N₃O₃

Colore e forma: White Off-White Powder

Peso molecolare: 389.4

Ref: 45-1448617

3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃

Purezza: 95%

Colore e forma: Solid

Peso molecolare: 389.3958

Ref: IN-DA001N5P

Moxifloxacin EP Impurity A HCl (Moxifloxacin USP Related Compound A HCl)

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃·HCl

Colore e forma: Pale Yellow Solid

Peso molecolare: 389.40 36.46

Ref: 4Z-M-2714

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS: 151213-15-9

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Purezza: 95%

Peso molecolare: 389.4g/mol

Ref: 54-PC1007442

1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

CAS: 151213-15-9

Colore e forma: Neat

Ref: 86-MM0885.04

Moxifloxacin EP Impurity A

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃

Peso molecolare: 389.40

Ref: ST-EA-CP-M26001

8-Desmethoxy-8-fluoro Moxifloxacin

CAS: 151213-15-9

Impurity Moxifloaxacin EP Impurity A
Stability Hygroscopic
Applications 8-Desmethoxy-8-fluoro Moxifloxacin (Moxifloaxacin EP Impurity A) is an impurity of Moxifloxacin (M745000).
References Martel, A., et al.: Drugs Fut., 22, 109 (1997), Tobin, C., et al.: J. Antimicrob. Chemother., 42, 278 (1998),

Formula: C₂₀H₂₁F₂N₃O₃

Colore e forma: Neat

Peso molecolare: 389.40

Ref: TR-D445850

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃

Purezza: 95%

Peso molecolare: 389.403

Ref: 10-F230378

8-Desmethoxy-8-fluoro moxifloxacin

CAS: 151213-15-9

8-Desmethoxy-8-fluoro moxifloxacin is a photolytic drug that is used to treat bacterial infections. It has a high degree of antibacterial activity against methicillin-resistant staphylococcus aureus, including methicillin resistant strains of Staphylococcus epidermidis. 8-Desmethoxy-8-fluoro moxifloxacin hydrochloride is produced by the addition of hydrochloric acid to moxifloxacin, which is then purified by ion chromatography. The compound has been shown to have good stability in human plasma and urine. It also shows excellent recoveries in acetonitrile and quantification results in flow rates.

Formula: C₂₀H₂₁F₂N₃O₃

Purezza: Min. 95%

Peso molecolare: 389.4 g/mol

Ref: 3D-FD21225